Biotech Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Anesthesia
Findings from H.A. Mowafi and co-researchers advance knowledge in anesthesia
May 12th, 2008
According to a study from Al Khobar, Saudi Arabia, "We hypothesized that pretreatment with IV granisetron would affect the sensory and motor components of spinal blockade through 5-HT3 receptor blockade. Forty unpremedicated patients scheduled for elective knee arthroscopy under spinal anesthesia were randomly allocated to receive either IV granisetron 1 mg (granisetron group) or saline (control group) on arrival to the operating room." "Two and half milliliters (12.5 mg) of hyperbaric bupivacaine 0.5% was injected intrathecally. Regression of the sensory level and motor blockade, and the hemodynamic changes were evaluated. There were no significant differences between...
Source: Biotech Business Week (2008-05-12)
|
